Recently, it was announced that Michael Douglas was diagnosed with throat cancer. His throat cancer is related to excessive smoking and alcohol use.

According to a recent article,

Another reason to suspect that Douglas’s throat cancer is oropharyngeal cancer is his statement that the cancer probably was caused by smoking and drinking.

‘Smoking is a major cause of oropharyngeal cancer,’ Har-El tells WebMD. ‘Drinking alcohol, as far as the statistics can tells us, is not as bad by itself. But the combination of drinking and smoking is the worst combination.’

Michael Douglas’s throat cancer is at the base of his tongue, a location that produces no pain, causing it to often progress undetected.

As always we urge you to have regular oral cancer screenings in order to protect you from this awful disease.

It’s always eye-opening when you come across the stories of those that have survived oral cancer and their battle against it. There is no one like a survivor that understands the “real deal”. Recently, we ran across an article of a chef that survived.  The article made a true assertion: we have to be our own advocates. It is up to the individual to really push the professional to look for oral cancer. Oral cancer is not easily diagnosed, so it should be monitored by the individual and second, third and even fourth opinions are worth the effort.

See below for a clip of the article discussing the type of oral cancer test that did not work for him and what he suggests for the reader. You can find the full article here.

The hardest part for Achatz is how easily the spot could have been identified as cancerous had doctors administered something called a “brush test.” “If even one of my dentists had used this simple test, my whole ordeal could have been avoided,” he writes. He urges anyone who sees or feels a spot on his or her tongue to see a dentist who uses the brush test, which tests the cells beneath the spot to see whether it is precancerous.

As always…

“Together we fight oral cancer. Together we save a life every hour.”

The National Institute of Dental and Craniofacial Research (NIDCR) reported recently that African Americans are at the highest risk for contracting oral cancer. In an effort to raise awareness and provide helpful information regarding risk factors, they have put together the below informative video. Please watch and feel free to offer any comments you might have.

Recently, Science Daily posted an article with updates on advancements in oral cancer research.  According to the article, early detection could save upwards of 40,000 people daily.  Below is an excerpt of this groundbreaking news:

“Case Western Reserve University School of Dental Medicine researchers discovered a biomarker, called human beta defensin-3 (hBD-3), which may serve as an early warning. The defensin is present in all oral cancers and associated with the early stages of oral cancer.

‘Using the biomarker to detect oral cancer holds potential for saving lives when the cancer is most curable. Annually some 10,000 people die from this cancer,’ said Ge Jin, assistant professor of biological sciences at the dental school.

He led the study, which appears in the online journal PLoS ONE, published by the Public Library of Science.

Oral cancer first appears as white or red lesions in the mouth, the same as noncancerous lesions.

Often, the lesions are not biopsied, and cancer is not discovered until it becomes apparent in its later stages, when it has metastasized to other organs. Such a late-stage diagnosis is generally fatal and can result in costly surgeries and treatments or disfigurement that may include removing parts of the tongue, jaw and cheek. All this can be avoided with early removal of the lesion.”

Click here for the complete Science Daily article regarding the role of hBDs in oral health and the potential of using this biomarker to detect oral cancer early.

Recently, we received a substantial donation from Michaeline Moran.  The donation was made in the memory of Phyllis Wolff, an oral cancer victim.  As a foundation, we’d like to thank Michaeline for her donation and offer our condolences to the friends and family of Phyllis Wolff.

***

Together we fight oral cancer… Together we save one life every hour.

Recently, we had a Twitter follower ask us what the latest methods of detecting oral cancer are. With Twitter’s allowances of only 140 characters to answer the question, we decided to post a blog that gives a more in depth look at the state of oral cancer detection devices.

The main oral cancer detection devices that are on the market today are:

1. Brush biopsy – “The OralCDx® BrushTest®is an easy, painless and definitive way for dentists to test the common small white and red oral spots that most people have in their mouth at one time or another. The BrushTest is used to determine if a common oral spot contains abnormal cells (known as dysplasia) that, if left alone for several years, may develop into oral cancer.”
2. ViziLite Plus, MicroLux DL – A light technology that “in combination with a regular visual examination, provides a comprehensive oral screening procedure for patients at increased risk for oral cancer.”
3. Velscope - “The ‘white light’ exam. The VELscope exam is actually the second step in a comprehensive oral cancer exam. The first step is a conventional ‘white light’ exam in which the dentist or hygienist looks for lesions in the oral cavity with the naked eye and uses palpation to feel for any bumps in the neck or face.”
4. Trimira OCS 3000 – Trimira’s®, new Identafi® 3000 ultra uses the Identafi® Multi-Spectral Fluorescence and Reflectance technology to enhance visualization of mucosal abnormalities such as oral cancer or premalignant dysplasia that may not be apparent to the naked eye. But unlike other fluorescence technologies and dye systems, the Identafi® 3000 ultra is Multi-Spectral with three distinct color wavelengths, making it easier to distinguish lesion morphology and vasculature thereby reducing false positives.

The oral cancer detection devices mentioned above are only tools for screening and are not designed to diagnose oral cancer. They result false negatives if not used appropriately.  The ideal screening is a conventional visual oral tactile exam at the dental office first.

Visiting a pathologist in suspicious cases is highly recommended.  A second opinion can save you a lifetime. Do not wait and watch the cancer grow in your mouth.

***

Together we fight oral cancer. Together we save a life every hour.

Photo Credit

May is the National Fight Oral Cancer Month.  The May Cover of The Journal of the American Dental Association magazine (JADA) is about oral cancer.  Below is an excerpt from the article.

The American Cancer Society (ACS) estimated that there would be 35,720 new cases of cancer of the oral and pharyngeal region in the United States in 2009, with 7,600 deaths from the disease.1 When focusing specifically on the oral cavity, ACS estimated that in 2009, there would be 23,110 new cases of cancer of the oral cavity (hereafter referred to as “oral cancer”) and 5,370 deaths. Nearly 90 percent of these malignancies are squamous cell carcinomas. More than 97 percent of U.S. cases of these cancers occur among adults 35 years and older. Although the incidence rate (IR) of oral and pharyngeal cancers is decreasing overall, the IR of cancers of the tongue, oropharynx and tonsil is increasing. The 2002–2006 age-adjusted (to the 2000 U.S. population) IR of oral and pharyngeal cancers in the United States was 10.3 per 100,000 per year. The age-adjusted IR was more than twice as high among men (15.9) as among women (6.0), as was the mortality rate (men, 4.0; women, 1.5).

Among the groups described in data from the National Cancer Institute’s Surveillance Epidemiology and End Results program, African-American men are at the highest risk of developing oral and pharyngeal cancers of any group in the United States (IR 16.7 per 100,000 per year). The five-year relative survival rate varies widely by stage at the time of diagnosis, from 81.8 percent for patients diagnosed in localized stages and 52.1 percent for patients with regional lymph node involvement to 26.5 percent for patients with distant metastasis. Yet, oral and pharyngeal cancer is diagnosed at a localized stage in only one-third of patients in the United States. The overall five-year relative survival rate for the 1999–2005 period was 61.0 percent and varied significantly by race (62.4 percent for white men and 38.2 percent for black men). Much of the racial disparity in survival rates was due to the greater proportion of tumors diagnosed at late stages among black men than among white men.

Click here for the full PDF of the ADA article on oral cancer.

Ever since we began The Fight Oral Cancer Foundation in 2008 with the slogan “Be a Life Saver”, we’ve been dedicated to giving towards the cause of fighting oral cancer.

Every dollar counts when it comes to saving a life.

Your donations* will go toward:

1. Educational pamphlet to be distributed at schools, hospitals, health fairs and public libraries locally and nationwide.
2. Provide dental care and dental hygiene educational programs for children.
3. Hold free oral cancer screenings locally and nationwide.
4. Sponsor speakers to raise awareness and promote screening.
5. Fund oral cancer research.

*95% of all donations go toward the foundation’s cause and only 5% is used to cover administrative expenses.

Join others as together we fight oral cancer.  Click here to donate.

Together we fight oral cancer. Together we save a life every hour.

When we hear the term “inoperable cancer”, a sense of hopelessness can often times accompany it.  Thus, when we hear of a new surgery that is making waves in the medical community and positively affects cancers that have been termed, inoperable, hope comes.  There is a new laser surgery that holds the following claim: “Patients with inoperable head and neck cancer have had tumours “drop off” after treatment with a new form of laser therapy, doctors say.”

Further claims of the new surgery as reported by the Health Correspondent for Times Online state:

Colin Hopper, a head and neck surgeon at the hospital, is leading the study. He said that patients with advanced or recurring cancers who had stopped responding to chemotherapy had experienced benefits.

One patient with an inoperable tumour on his tongue saw it disappear completely, while another, with advanced sarcoma on his jaw, lived for six months, far longer than doctors previously predicted.

Although news of oral cancer never falls on a willing ear, there is still hope.  Technology is advancing and the world is standing strong as we support those that are working feverishly to find a cure.

Click here for the complete article titled: Inoperable cancers killed by new laser surgery

A FREE Oral Cancer Screening will be held at Baylor between 9am and 12 noon on Saturday, April 17, 2010 at Baylor in Downtown Dallas.  For the full sized brochure click this link: Oral Cancer Screening.